These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6301844)

  • 1. Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids.
    Field EJ; Joyce G
    Eur Neurol; 1983; 22(1):78-83. PubMed ID: 6301844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prolonged ingestion of gamma-linolenate by MS patients.
    Field EJ; Joyce G
    Eur Neurol; 1978; 17(2):67-76. PubMed ID: 631143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsaturated fatty acids in multiple sclerosis.
    Mertin J; Shenton BK; Field EJ
    Br Med J; 1973 Jun; 2(5869):777-8. PubMed ID: 4718333
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of gamma-linolenate in multiple sclerosis.
    Meyer-Rienecker JH; Jenssen HL; Kohler H; Field EJ; Shenton BK
    Lancet; 1976 Oct; 2(7992):966. PubMed ID: 62196
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitory effect of unsaturated fatty acids on lymphocyte-antigen interaction with special reference to multiple sclerosis.
    Field EJ; Shenton BK
    Acta Neurol Scand; 1975 Aug; 52(2):121-36. PubMed ID: 1155030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated fatty acids and colchicine in multiple sclerosis.
    Br Med J; 1979 Feb; 1(6160):411-2. PubMed ID: 761034
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
    Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F
    Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma-Linolenate in multiple schlerosis.
    Field EJ
    Lancet; 1978 Apr; 1(8067):780. PubMed ID: 76789
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease.
    Field EJ; Joyce G; Smith BM
    J Neurol; 1977 Jan; 214(2):113-27. PubMed ID: 64595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acids in multiple sclerosis.
    Field EJ
    Br Med J; 1979 Apr; 1(6169):1016-7. PubMed ID: 435921
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipids and multiple sclerosis.
    Bates D
    Biochem Soc Trans; 1989 Apr; 17(2):289-91. PubMed ID: 2546837
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1978 Nov; 2(6149):1390-1. PubMed ID: 363236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood serum linoleic, linolenic and arachidonic acids in patients with multiple sclerosis.
    Rosnowska M; Piesio B; Cendrowski W
    Acta Med Pol; 1979; 20(3):273-80. PubMed ID: 517165
    [No Abstract]   [Full Text] [Related]  

  • 14. Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis.
    Tamblyn CH; Swank RL; Seaman GV; Zukoski CF
    Neurol Res; 1980; 2(1):69-83. PubMed ID: 6114451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance and motivation of the clinical use of essential fatty acid derivatives, especially gamma-linolenic acid].
    Bordoni A
    Clin Ter; 1990 Mar; 132(6):383-92. PubMed ID: 2158408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effects of arachidonic, linoleic, linolenic, and oleic acid, and the influence of indomethacin and polyphloretinephosphate.
    Forster W; Mentz P; Blass KE; Mest HJ
    Adv Prostaglandin Thromboxane Res; 1976; 1():433-8. PubMed ID: 998437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further observations with the erythrocyte-unsaturated fatty acid test. A contribution to the genetics of multiple sclerosis.
    Joyce G; Field EJ
    Eur Neurol; 1980; 19(4):266-72. PubMed ID: 7398689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential fatty acid supplementation in tardive dyskinesia.
    Wolkin A; Jordan B; Peselow E; Rubinstein M; Rotrosen J
    Am J Psychiatry; 1986 Jul; 143(7):912-4. PubMed ID: 3013033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis.
    Biagi PL; Bordoni A; Hrelia S; Celadon M; Ricci GP; Cannella V; Patrizi A; Specchia F; Masi M
    Drugs Exp Clin Res; 1994; 20(2):77-84. PubMed ID: 7924900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.